NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Operating margin 2016–2021
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) operating margin by fiscal year — reported operating income divided by reported revenue.
-250080.0%FY2021 · since FY2016: -466.1% → -250080.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -250080.0% | -239976.6 pp |
| FY2020 | -10103.4% | -5646.9 pp |
| FY2019 | -4456.5% | +293.9 pp |
| FY2018 | -4750.4% | -90.2 pp |
| FY2017 | -4660.2% | -4194.1 pp |
| FY2016 | -466.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NYMXF financial trends
NYMXF RevenueNYMXF Net incomeNYMXF Net marginNYMXF Gross profitNYMXF Gross marginNYMXF Operating incomeNYMXF Operating cash flowNYMXF Free cash flowNYMXF Capital expendituresNYMXF Return on equityNYMXF Stock buybacksNYMXF Dividends paidNYMXF Total assetsNYMXF Total liabilitiesNYMXF Shareholders’ equityNYMXF overview →